SEC Form 4/A · accession 0001209191-15-084500
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jeffrey W Sherman
Officer — EVP and Chief Medical Officer
Period of report
Dec 8, 2015
Accepted (ET)
Dec 10, 2015 · 4:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Dec 8, 2015 | M | 8,208 | — | A | 113,340 | D | |
| Ordinary Shares | Dec 8, 2015 | F | 3,752 | $20.40 | D | 109,588 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Dec 8, 2015 | M | 8,208 | D | — | — | Ordinary Shares | 8,208 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2On December 8, 2011, the reporting person was granted 32,832 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
Remarks
This amendment is being filed to correct the clerical error made in the price of the securities disposed in Column 4 of Table I of the Form 4 originally filed on December 9, 2015.